US 10799559
NOPE for treatment of pathological muscle loss and weakness
granted A61KA61K38/1774A61P
Quick answer
US patent 10799559 (NOPE for treatment of pathological muscle loss and weakness) held by Five Prime Therapeutics, Inc. expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/1774, A61P, A61P21/00, A61P25/28